October 2006 โ Taxotere was approved for use in combination with cisplatin and fluorouracil for patients being treated for inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Reference: โTAXOTEREยฎ Receives U.S. FDA Approval for the Treatment of Patients with Head and Neck Cancer.โ Sanofi, www.news.sanofi.us/press-releases?item=118381